VENOUS THROMBOEMBOLISM (VTE)
Clinical trials for VENOUS THROMBOEMBOLISM (VTE) explained in plain language.
Never miss a new study
Get alerted when new VENOUS THROMBOEMBOLISM (VTE) trials appear
Sign up with your email to follow new studies for VENOUS THROMBOEMBOLISM (VTE), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail aims to save hearts after hip fractures
Disease control Not yet recruitingThis study tests whether a combination of two blood thinners (rivaroxaban and aspirin) can prevent heart attacks, strokes, and blood clots in people who had hip fracture surgery and also suffered a heart injury. About 100 adults aged 45 and older will receive either the drug comb…
Matched conditions: VENOUS THROMBOEMBOLISM (VTE)
Phase: PHASE3 • Sponsor: McMaster University • Aim: Disease control
Last updated May 26, 2026 10:51 UTC
-
New hope for DVT patients: common arthritis drug may prevent lasting vein damage
Disease control Not yet recruitingThis study tests whether adding colchicine, an anti-inflammatory medicine, to standard blood thinners can reduce the risk of long-term vein damage (post-thrombotic syndrome) in people with a first-time deep vein clot in the leg. About 940 adults will receive either colchicine or …
Matched conditions: VENOUS THROMBOEMBOLISM (VTE)
Phase: PHASE3 • Sponsor: Azienda Sanitaria Locale ASL 6, Livorno • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
Could a simple aspirin pill replace painful injections for hip fracture patients?
Disease control Not yet recruitingThis study will compare two common treatments—aspirin tablets and heparin injections—to see which is better at preventing dangerous blood clots in people who break their hip. Over 21,000 patients aged 60 and older from 96 UK hospitals will take part. Hospitals will switch between…
Matched conditions: VENOUS THROMBOEMBOLISM (VTE)
Phase: NA • Sponsor: Queen Mary University of London • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
New drug aims to stop dangerous blood clots in cancer patients
Disease control Not yet recruitingThis study tests an experimental drug, REGN7508, to see if it works better than the standard blood thinner apixaban for treating and preventing blood clots in people with cancer. About 1,600 participants with or without cancer will be enrolled. The goal is to check how safe and e…
Matched conditions: VENOUS THROMBOEMBOLISM (VTE)
Phase: PHASE3 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated May 19, 2026 12:01 UTC
-
New Radiation-Free scan could spot dangerous lung clots in minutes
Diagnosis Not yet recruitingThis study will test a new, non-invasive bedside imaging technique called 3D electrical impedance tomography (3D-EIT) to see if it can accurately diagnose and monitor pulmonary embolism (blood clots in the lungs). About 115 adults with and without clots will be scanned, and the r…
Matched conditions: VENOUS THROMBOEMBOLISM (VTE)
Sponsor: Beijing Tsinghua Chang Gung Hospital • Aim: Diagnosis
Last updated May 22, 2026 13:53 UTC
-
New study aims to stop silent killer clots in hospitalized teens
Prevention Not yet recruitingThis study tests whether a blood thinner called enoxaparin can prevent dangerous blood clots in critically ill teenagers. About 802 teens aged 12-18 in intensive care with a central line and infection will be enrolled. The goal is to see if the drug safely reduces clot risk witho…
Matched conditions: VENOUS THROMBOEMBOLISM (VTE)
Phase: PHASE3 • Sponsor: Johns Hopkins All Children's Hospital • Aim: Prevention
Last updated May 22, 2026 14:03 UTC
-
New moms get video relief before needle: study
Symptom relief Not yet recruitingThis study tests whether watching a short educational video before receiving a blood thinner injection (LMWH) after childbirth can reduce anxiety and pain. About 160 new mothers will either get the usual explanation or also watch the video. The goal is to see if the video helps t…
Matched conditions: VENOUS THROMBOEMBOLISM (VTE)
Phase: NA • Sponsor: Wolfson Medical Center • Aim: Symptom relief
Last updated May 19, 2026 12:00 UTC
-
Can virtual care cut hospital falls and infections? duke launches massive study
Knowledge-focused Not yet recruitingThis study will see if using virtual care technologies in hospital units can reduce problems like falls, infections, and readmissions while improving patient satisfaction. About 10,000 adults admitted to six hospital units at Duke University Hospital will take part. Three units w…
Matched conditions: VENOUS THROMBOEMBOLISM (VTE)
Sponsor: Duke University • Aim: Knowledge-focused
Last updated May 26, 2026 10:43 UTC